Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain

Insights from basic science and clinical studies

Judith L Turgeon, Molly C. Carr, Pauline M. Maki, Michael E. Mendelsohn, Phyllis M. Wise

Research output: Contribution to journalArticle

195 Citations (Scopus)

Abstract

Recent publications describing the results of the Women's Health Initiative (WHI) and other studies reporting the impact of hormone therapy on aging women have spurred reexamination of the broad use of estrogens and progestins during the postmenopausal years. Here, we review the complex pharmacology of these hormones, the diverse and sometimes opposite effects that result from the use of different estrogenic and progestinic compounds, given via different delivery routes in different concentrations and treatment sequence, and to women of different ages and health status. We examine our new and growing appreciation of the role of estrogens in the immune system and the inflammatory response, and we pose the concept that estrogen's interface with this system may be at the core of some of the effects on multiple physiological systems, such as the adipose/metabolic system, the cardiovascular system, and the central nervous system. We compare and contrast clinical and basic science studies as we focus on the actions of estrogens in these systems because the untoward effects of hormone therapy reported in the WHI were not expected. The broad interpretation and publicity of the results of the WHI have resulted in a general condemnation of all hormone replacement in postmenopausal women. In fact, careful review of the extensive literature suggests that data resulting from the WHI and other recent studies should be interpreted within the narrow context of the study design. We argue that these results should encourage us to perform new studies that take advantage of a dialogue between basic scientists and clinician scientists to ensure appropriate design, incorporation of current knowledge, and proper interpretation of results. Only then will we have a better understanding of what hormonal compounds should be used in which populations of women and at what stages of menopausal/postmenopausal life.

Original languageEnglish (US)
Pages (from-to)575-605
Number of pages31
JournalEndocrine Reviews
Volume27
Issue number6
DOIs
StatePublished - 2006

Fingerprint

Cardiovascular System
Adipose Tissue
Women's Health
Estrogens
Steroids
Hormones
Brain
Progestins
Health Status
Immune System
Therapeutics
Central Nervous System
Clinical Studies
Pharmacology
Population

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain : Insights from basic science and clinical studies. / Turgeon, Judith L; Carr, Molly C.; Maki, Pauline M.; Mendelsohn, Michael E.; Wise, Phyllis M.

In: Endocrine Reviews, Vol. 27, No. 6, 2006, p. 575-605.

Research output: Contribution to journalArticle

Turgeon, Judith L ; Carr, Molly C. ; Maki, Pauline M. ; Mendelsohn, Michael E. ; Wise, Phyllis M. / Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain : Insights from basic science and clinical studies. In: Endocrine Reviews. 2006 ; Vol. 27, No. 6. pp. 575-605.
@article{d47c69a3e5d84d1796c63a6dda673073,
title = "Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies",
abstract = "Recent publications describing the results of the Women's Health Initiative (WHI) and other studies reporting the impact of hormone therapy on aging women have spurred reexamination of the broad use of estrogens and progestins during the postmenopausal years. Here, we review the complex pharmacology of these hormones, the diverse and sometimes opposite effects that result from the use of different estrogenic and progestinic compounds, given via different delivery routes in different concentrations and treatment sequence, and to women of different ages and health status. We examine our new and growing appreciation of the role of estrogens in the immune system and the inflammatory response, and we pose the concept that estrogen's interface with this system may be at the core of some of the effects on multiple physiological systems, such as the adipose/metabolic system, the cardiovascular system, and the central nervous system. We compare and contrast clinical and basic science studies as we focus on the actions of estrogens in these systems because the untoward effects of hormone therapy reported in the WHI were not expected. The broad interpretation and publicity of the results of the WHI have resulted in a general condemnation of all hormone replacement in postmenopausal women. In fact, careful review of the extensive literature suggests that data resulting from the WHI and other recent studies should be interpreted within the narrow context of the study design. We argue that these results should encourage us to perform new studies that take advantage of a dialogue between basic scientists and clinician scientists to ensure appropriate design, incorporation of current knowledge, and proper interpretation of results. Only then will we have a better understanding of what hormonal compounds should be used in which populations of women and at what stages of menopausal/postmenopausal life.",
author = "Turgeon, {Judith L} and Carr, {Molly C.} and Maki, {Pauline M.} and Mendelsohn, {Michael E.} and Wise, {Phyllis M.}",
year = "2006",
doi = "10.1210/er.2005-0020",
language = "English (US)",
volume = "27",
pages = "575--605",
journal = "Endocrine Reviews",
issn = "0163-769X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain

T2 - Insights from basic science and clinical studies

AU - Turgeon, Judith L

AU - Carr, Molly C.

AU - Maki, Pauline M.

AU - Mendelsohn, Michael E.

AU - Wise, Phyllis M.

PY - 2006

Y1 - 2006

N2 - Recent publications describing the results of the Women's Health Initiative (WHI) and other studies reporting the impact of hormone therapy on aging women have spurred reexamination of the broad use of estrogens and progestins during the postmenopausal years. Here, we review the complex pharmacology of these hormones, the diverse and sometimes opposite effects that result from the use of different estrogenic and progestinic compounds, given via different delivery routes in different concentrations and treatment sequence, and to women of different ages and health status. We examine our new and growing appreciation of the role of estrogens in the immune system and the inflammatory response, and we pose the concept that estrogen's interface with this system may be at the core of some of the effects on multiple physiological systems, such as the adipose/metabolic system, the cardiovascular system, and the central nervous system. We compare and contrast clinical and basic science studies as we focus on the actions of estrogens in these systems because the untoward effects of hormone therapy reported in the WHI were not expected. The broad interpretation and publicity of the results of the WHI have resulted in a general condemnation of all hormone replacement in postmenopausal women. In fact, careful review of the extensive literature suggests that data resulting from the WHI and other recent studies should be interpreted within the narrow context of the study design. We argue that these results should encourage us to perform new studies that take advantage of a dialogue between basic scientists and clinician scientists to ensure appropriate design, incorporation of current knowledge, and proper interpretation of results. Only then will we have a better understanding of what hormonal compounds should be used in which populations of women and at what stages of menopausal/postmenopausal life.

AB - Recent publications describing the results of the Women's Health Initiative (WHI) and other studies reporting the impact of hormone therapy on aging women have spurred reexamination of the broad use of estrogens and progestins during the postmenopausal years. Here, we review the complex pharmacology of these hormones, the diverse and sometimes opposite effects that result from the use of different estrogenic and progestinic compounds, given via different delivery routes in different concentrations and treatment sequence, and to women of different ages and health status. We examine our new and growing appreciation of the role of estrogens in the immune system and the inflammatory response, and we pose the concept that estrogen's interface with this system may be at the core of some of the effects on multiple physiological systems, such as the adipose/metabolic system, the cardiovascular system, and the central nervous system. We compare and contrast clinical and basic science studies as we focus on the actions of estrogens in these systems because the untoward effects of hormone therapy reported in the WHI were not expected. The broad interpretation and publicity of the results of the WHI have resulted in a general condemnation of all hormone replacement in postmenopausal women. In fact, careful review of the extensive literature suggests that data resulting from the WHI and other recent studies should be interpreted within the narrow context of the study design. We argue that these results should encourage us to perform new studies that take advantage of a dialogue between basic scientists and clinician scientists to ensure appropriate design, incorporation of current knowledge, and proper interpretation of results. Only then will we have a better understanding of what hormonal compounds should be used in which populations of women and at what stages of menopausal/postmenopausal life.

UR - http://www.scopus.com/inward/record.url?scp=33750042898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750042898&partnerID=8YFLogxK

U2 - 10.1210/er.2005-0020

DO - 10.1210/er.2005-0020

M3 - Article

VL - 27

SP - 575

EP - 605

JO - Endocrine Reviews

JF - Endocrine Reviews

SN - 0163-769X

IS - 6

ER -